1. Net remission rates with biologic and small molecule treatment in ulcerative colitis: a reappraisal of the clinical trial data;Kayal;Clin Gastroenterol Hepatol,2023
2. Inflammatory bowel disease (IBD) in rural and urban India: results from community colonoscopic evaluation of more than 30,000 symptomatic patients;Banerjee;Lancet Reg Health Southeast Asia,2023
3. Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn’s disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial;Louis;Lancet Gastroenterol Hepatol,2023
4. A combined risk score enhances prediction of type 1 diabetes among susceptible children;Ferrat;Nat Med,2020
5. An Anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes;Herold;N Engl J Med,2019